Stephen Hoffman

Stephen Hoffman possesses extensive experience in the biotechnology and pharmaceutical sectors, currently serving on the Board of Directors for multiple companies, including Implicit Bioscience, AcelRx Pharmaceuticals, and BYOMass. Hoffman's previous roles include Chairman at Apic Bio and Chief Executive Officer at Aerpio Pharmaceuticals, where leadership resulted in a successful $50+ million financing and uplisting to NASDAQ. With an MD from the University of Colorado School of Medicine and a PhD in Chemistry from Northwestern University, Hoffman brings a strong educational background to their leadership roles in the industry.